Perspective Therapeutics News

Perspective Therapeutics | 424B5: Prospectus

May 24 09:17 ET

Perspective Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

May 24 07:11 ET

Perspective Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

May 24 07:01 ET

Perspective Therapeutics | 8-K: Current report

May 20 17:26 ET

Perspective Therapeutics | SD: Specialized disclosure report

May 16 15:23 ET

Perspective Therapeutics | 10-Q: Quarterly report

May 15 22:44 ET

Perspective Therapeutics | 8-K: Current report

May 15 07:05 ET

Perspective Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Austin Mark John

Apr 24 16:40 ET

Perspective Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Commodore Capital LP(6.6%),Commodore Capital Master LP(6.6%)

Apr 19 16:10 ET

Perspective Therapeutics | DEFA14A: Others

Apr 18 16:17 ET

Perspective Therapeutics | DEF 14A: Definitive information statements

Apr 18 16:12 ET

Perspective Therapeutics | 8-K: Current report

Apr 16 16:11 ET

Perspective Therapeutics | EFFECT: Others

Apr 10 06:07 ET

Perspective Therapeutics | 424B3: Prospectus

Apr 9 16:30 ET

Perspective Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 8 16:14 ET

Perspective Therapeutics | 8-K: Current report

Apr 8 16:10 ET

Perspective Therapeutics | UPLOAD: Others

Apr 8 14:58 ET

Perspective Therapeutics | CORRESP: CORRESP

Apr 8 14:58 ET

Perspective Therapeutics | 8-K: Current report

Apr 3 16:41 ET

Perspective Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Apr 1 07:50 ET